Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04MBD
|
|||
| Former ID |
DNC011458
|
|||
| Drug Name |
1,8-Dichloro-10H-anthracen-9-one
|
|||
| Synonyms |
1,8-Dichloro-10H-anthracen-9-one; CHEMBL122022; 50259-93-3; NSC162539; 1,8-Dichloroanthrone; AC1Q3KGA; AC1L9O6M; SCHEMBL7103871; CTK1H2907; DTXSID70329816; ZINC393214; BDBM50060867; AKOS024331862; NSC-162539; MCULE-9362278595
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H8Cl2O
|
|||
| Canonical SMILES |
C1C2=C(C(=CC=C2)Cl)C(=O)C3=C1C=CC=C3Cl
|
|||
| InChI |
1S/C14H8Cl2O/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6H,7H2
|
|||
| InChIKey |
AYDNUUZHQKPRKA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 50259-93-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. J Med Chem. 1997 Nov 7;40(23):3773-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.